Higher Doses of Subcutaneous IgG Reduce Resource Utilization in Patients with Primary Immunodeficiency

The recommended dose of IgG in primary immunodeficiency (PID) has been increasing since its first use. This study aimed to determine if higher subcutaneous IgG doses resulted in improved patient outcomes by comparing results from two parallel clinical studies with similar design. One patient cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Haddad, Elie, Berger, Melvin, Wang, Edward C. Y., Jones, Christopher A., Bexon, Martin, Baggish, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305876/
https://www.ncbi.nlm.nih.gov/pubmed/22193916
http://dx.doi.org/10.1007/s10875-011-9631-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305876/
https://www.ncbi.nlm.nih.gov/pubmed/22193916
http://dx.doi.org/10.1007/s10875-011-9631-6

Ejemplares similares